INLURIYO Trademark (Class 5) — Registered Status & Details
Source: Indian Trademark Registry (ipindia.gov.in) · IP India record as of 10/07/2026 · Last updated 10 Jul 2026
Trademark Fact Sheet
- Trademark (as filed)
- INLURIYOWORD
- Application No.
- 5975441
- Filed
- 12/06/2023
- Status
- Registered
- Class(es)
- Class 5
- TM Office
- DELHI
- Owner's state
- Delhi
- TM type
- WORD
- Valid upto
- 12/06/2033
- Published in Journal
- Published in Journal No. : 2151-0 Dated : 08/04/2024
Goods & Services
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson’s disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; pharmaceutical preparations.
Owner
- Name
- Eli Lilly and Company Body Incorporate6 trademarks filed under this owner
- Address
- *****, Indiana 46285, United States of America(dot)
- *********rks(at)indiaip.com
- State
- Delhi
Other trademarks by this owner
5 other marks filed under Eli Lilly and Company Body Incorporate. Live marks link to their full details.
| Wordmark | App No. | Class | Status |
|---|---|---|---|
| CUBE (Logo) TM #8003657 · Filed 17/09/2026 | 8003657 | Class 44 | Send To Vienna Codification |
| CUBE (Logo) TM #8003656 · Filed 17/09/2026 | 8003656 | Class 5 | Send To Vienna Codification |
| CUBE (Logo) TM #8003655 · Filed 17/09/2026 | 8003655 | Class 44 | Send To Vienna Codification |
| CUBE (Logo) TM #8003654 · Filed 17/09/2026 | 8003654 | Class 5 | Send To Vienna Codification |
| TIZARO TM #6961908 · Filed 17/04/2025 | 6961908 | Class 5 | Formalities Chk Pass |
Application Timeline
Uploaded Documents
4 documents filed with the Trade Marks Registry for this application.
| # | Document | Date |
|---|---|---|
| 1 | TM-A(TRADE MARKS APPLICATION) | 12 Jun 2023 |
| 2 | Reply to Exam Report (MIS-R) | 18 Mar 2024 |
| 3 | Journal Copy | 26 Jul 2024 |
| 4 | Certificate | 16 Sep 2024 |
Filing claims & diligence
- First use claim
- Proposed to be used
- Filing mode
- e-Filing
- Category
- TRADE MARK
Attorney / IP Agent
- Name & code
- LALL & SETHI[23687]
- Address
- *****, New Delhi 110049, India
What does this status mean?
INLURIYO is a registered trademark in Class 5. The owner holds exclusive rights to use this mark for Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson’s disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; pharmaceutical preparations. and can renew it to keep the protection in force. Planning a similar mark in Class 5? It may be blocked — check availability before you file.
Frequently asked questions
The trademark INLURIYO (Application No. 5975441) is owned by (1) Eli Lilly and, as recorded in the Indian Trademark Registry. Trademark ownership in India is determined by the Trade Marks Act, 1999 and the Trade Marks Rules, 2017.
The current status of INLURIYO is "Registered". It was filed on 12/06/2023 at DELHI in Class 5. Status may change over time as the application moves through examination, publication, opposition and registration stages.
INLURIYO is filed in Class 5, covering: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson’s disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; pharmaceutical preparations.
INLURIYO covers: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson’s disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; pharmaceutical preparations.
The exact word "INLURIYO" is already on record at the Indian Trademark Registry under Application No. 5975441. If you intend to use a similar mark for similar goods or services, you should conduct a comprehensive availability search and consult a trademark attorney before filing. Registerkaro offers a free availability check followed by professional filing.
INLURIYO is valid up to 12/06/2033. Indian trademarks are valid for 10 years from the date of registration and can be renewed indefinitely in 10-year blocks.
If INLURIYO is in the "Advertised before Acceptance" or "Accepted & Advertised" stage, you have a 4-month window from publication in the Trade Marks Journal to file an opposition (Form TM-O) at the same Trade Marks Registry office. Grounds typically include prior rights, descriptiveness or bad faith. Registerkaro can prepare and file a Notice of Opposition for you.
— Public Notice —
Protect a mark like "INLURIYO"
Free availability check, attorney drafting, and end-to-end TM-A filing through Registerkaro. Pick the plan that fits — government fee additional.
For individuals or companies who just want to file a trademark.
- Help choosing the right trademark class
- Drafting & Filing by TM Expert + Power of Attorney form
- Acknowledgement Receipt
- TM usage guide